DCLX069
DCLX069 is a selective PRMT1 inhibitor (IC50 = 17.9 μM) that functions by occupying the S-adenosylmethionine (SAM) binding site. It has demonstrated efficacy in suppressing proliferation in various cancer cell lines, including breast cancer, liver cancer, and acute myeloid leukemia, making it a useful tool for epigenetic and oncology research.
Product Specifications
CAS Number
792946-69-1
Product Name Alternative
Anticancer, inhibit, Inhibitor, Histone Methyltransferase, HistoneMethyltransferase, DCLX 069, DCLX069, DCLX-069, PRMT1
Field of Research
Epigenetics & Chromatin
Purity
97.76% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.89 mM) ; DMSO:60 mg/mL (176.77 mM)
Smiles
CCOC (=O) C1=CC (N) =C (C=C1) N1CCN (CC2=CC=CC=C2) CC1
Molecular Formula
C20H25N3O2
Molecular Weight
339.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PPM1D Polyclonal Antibody, AbBy Fluor™ 488 Conjugated
Anti-SEPT7/SEPTIN7 Antibody Picoband®, HRP Conjugate
Lentiviral mouse Ceacam20 shRNA (UAS) - Lentiviral mouse Ceacam20 shRNA (UAS, RFP) plasmid